搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
10 天
杜立:生物制药的法律规范与监管挑战|生物制药的创新与监管研讨会
杜立在演讲中指出,中国与美国的医疗环境和政策差距巨大,因此在发展生物制药的策略上应充分考虑自身国情。他认为,就整个医疗系统而言,医疗改革对创新生物制药研发的影响尤为显著,由于生物制药在国内定价偏低,许多初创团队在药物临床试验阶段将药物出售给国外公司, ...
3 天
TED | 你可能错过的好消息
记者安格斯‧赫维(Angus Hervey)说,你是否相信世界末日可能取决于你从哪里获得新闻。他讲述了主流媒体机构去年错过的进展——从清洁能源的进步到极端贫困率、犯罪率和疾病率的下降——并建议我们应该更多地关注此类事件。赫维说:“如果我们希望更多的人致力于取得进步,那么也许我们应该告诉更多的人取得进步是可能的。” ...
1 个月
on MSN
First gene-editing therapy may cure blood disorder
The first therapy that uses gene-editing is to be offered on the NHS in a “revolutionary breakthrough” for patients. It will ...
WUNC
4 天
Sickle cell gene therapies roll out slowly
It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.
来自MSN
8 天
Understanding iron overload in β-thalassemia: Mechanisms, diagnosis, and treatments
β-Thalassemia is a genetic disorder characterized by reduced or absent synthesis of the beta chains of hemoglobin, leading to ineffective erythropoiesis and severe anemia. Patients with ...
4 天
on MSN
1 growth stock that could skyrocket over the next 10 years
This investor is excited about the transformational potential of one growth stock that he's been eyeing up for his portfolio.
1 天
The Best Biotech Stock to Invest $1,000 in Right Now
Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
5 天
on MSN
7 Top Gene-Editing Stocks to Buy
Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $29.9 billion by 2032, ...
9 天
Got $200? 2 Healthcare Stocks to Buy and Hold Forever
For those with $200 to spare that isn't being saved for emergencies, let's consider two healthcare stocks within that budget ...
3 天
Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews
The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...
3 天
The best biotech plays outside the GLP-1 weight-loss market
BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best ...
11 天
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈